However, the observed early-onset pseudoprogression, as well as a positive proximity ligation assay, suggest a relevant and functional CD4+ T cell response in vivo against the primary tumor presenting the neoepitope H3K27M on HLA-DR molecules. This evidence concerns the gene CD4 and neoplasm.